SGT-001
GX1001
Phase 2 gene_therapy active
Quick answer
SGT-001 for Duchenne Muscular Dystrophy is a Phase 2 program (gene_therapy) at Solid Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Solid Biosciences
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active